OPTIMIZING ANTIEMESIS IN CANCER-CHEMOTHERAPY - EFFICACY OF CONTINUOUS VERSUS INTERMITTENT INFUSION OF HIGH-DOSE METOCLOPRAMIDE IN EMESIS INDUCED BY CISPLATIN

被引:49
作者
WARRINGTON, PS
ALLAN, SG
CORNBLEET, MA
MACPHERSON, JS
SMYTH, JF
LEONARD, RCF
机构
关键词
D O I
10.1136/bmj.293.6558.1334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1334 / 1337
页数:4
相关论文
共 12 条
[1]   EMESIS DUE TO CANCER-CHEMOTHERAPY - RESULTS OF A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TRIAL OF VARYING DOSES OF METOCLOPRAMIDE IN THE MANAGEMENT OF CIS-PLATINUM-INDUCED VOMITING [J].
ALLAN, SG ;
CORNBLEET, MA ;
LOCKHART, SP ;
WARRINGTON, PS ;
LEONARD, RCF ;
SMYTH, JF .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (12) :1481-1484
[2]   DEXAMETHASONE AND HIGH-DOSE METOCLOPRAMIDE - EFFICACY IN CONTROLLING CISPLATIN INDUCED NAUSEA AND VOMITING [J].
ALLAN, SG ;
CORNBLEET, MA ;
WARRINGTON, PS ;
GOLLAND, IM ;
LEONARD, RCF ;
SMYTH, JF .
BRITISH MEDICAL JOURNAL, 1984, 289 (6449) :878-879
[3]   THE PHARMACOKINETICS OF SINGLE DOSES OF METOCLOPRAMIDE IN RENAL-FAILURE [J].
BATEMAN, DN ;
GOKAL, R ;
DODD, TRP ;
BLAIN, PG .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (06) :437-441
[4]   ON THE RECEIVING END PATIENT PERCEPTION OF THE SIDE-EFFECTS OF CANCER-CHEMOTHERAPY [J].
COATES, A ;
ABRAHAM, S ;
KAYE, SB ;
SOWERBUTTS, T ;
FREWIN, C ;
FOX, RM ;
TATTERSALL, MHN .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02) :203-208
[5]   ANTI-EMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE - RANDOMIZED TRIALS WITH PLACEBO AND PROCHLORPERAZINE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING [J].
GRALLA, RJ ;
ITRI, LM ;
PISKO, SE ;
SQUILLANTE, AE ;
KELSEN, DP ;
BRAUN, DW ;
BORDIN, LA ;
BRAUN, TJ ;
YOUNG, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (16) :905-909
[6]   INCIDENCE, COURSE, AND SEVERITY OF DELAYED NAUSEA AND VOMITING FOLLOWING THE ADMINISTRATION OF HIGH-DOSE CISPLATIN [J].
KRIS, MG ;
GRALLA, RJ ;
CLARK, RA ;
TYSON, LB ;
OCONNELL, JP ;
WERTHEIM, MS ;
KELSEN, DP .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (10) :1379-1384
[7]   CLINICAL PHARMACOKINETICS OF HIGH-DOSE METOCLOPRAMIDE IN CANCER-PATIENTS RECEIVING CISPLATIN THERAPY [J].
MCDERMED, JE ;
COHEN, JL ;
JOSEPH, C ;
STRUM, SB .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (10) :1400-1408
[8]  
MEYER RB, 1984, ANN INTERN MED, V100, P363
[9]   INTRAVENOUS METOCLOPRAMIDE - AN EFFECTIVE ANTIEMETIC IN CANCER-CHEMOTHERAPY [J].
STRUM, SB ;
MCDERMED, JE ;
OPFELL, RW ;
RIECH, LP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (19) :2683-2686
[10]   HIGH-DOSE METOCLOPRAMIDE - PRELIMINARY PHARMACOKINETIC STUDIES [J].
TAYLOR, WB ;
BATEMAN, DN .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (03) :341-342